APH vs. SPI, ESP, RTN, IPF, SGM, MSI, BERI, MCP, AMAT, and STM
Should you be buying Alliance Pharma stock or one of its competitors? The main competitors of Alliance Pharma include Spire Healthcare Group (SPI), Empiric Student Property (ESP), The Restaurant Group (RTN), International Personal Finance (IPF), Sigma Capital Group (SGM), MS INTERNATIONAL (MSI), BlackRock Energy and Resources (BERI), Martin Currie Asia Unconstrand Trust (MCP), Amati AIM VCT (AMAT), and STM Group (STM). These companies are all part of the "electronic equipment" industry.
Alliance Pharma vs.
Alliance Pharma (LON:APH) and Spire Healthcare Group (LON:SPI) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, community ranking, profitability, valuation and analyst recommendations.
Alliance Pharma pays an annual dividend of GBX 2 per share and has a dividend yield of 4.5%. Spire Healthcare Group pays an annual dividend of GBX 3 per share and has a dividend yield of 1.4%. Alliance Pharma pays out -3,333.3% of its earnings in the form of a dividend. Spire Healthcare Group pays out 4,285.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Alliance Pharma is clearly the better dividend stock, given its higher yield and lower payout ratio.
Alliance Pharma presently has a consensus price target of GBX 60, indicating a potential upside of 33.70%. Spire Healthcare Group has a consensus price target of GBX 322, indicating a potential upside of 49.20%. Given Spire Healthcare Group's higher possible upside, analysts clearly believe Spire Healthcare Group is more favorable than Alliance Pharma.
Spire Healthcare Group received 152 more outperform votes than Alliance Pharma when rated by MarketBeat users. However, 62.08% of users gave Alliance Pharma an outperform vote while only 60.89% of users gave Spire Healthcare Group an outperform vote.
Spire Healthcare Group has higher revenue and earnings than Alliance Pharma. Alliance Pharma is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, Spire Healthcare Group had 2 more articles in the media than Alliance Pharma. MarketBeat recorded 2 mentions for Spire Healthcare Group and 0 mentions for Alliance Pharma. Spire Healthcare Group's average media sentiment score of 0.44 beat Alliance Pharma's score of 0.00 indicating that Spire Healthcare Group is being referred to more favorably in the news media.
66.3% of Alliance Pharma shares are held by institutional investors. Comparatively, 50.4% of Spire Healthcare Group shares are held by institutional investors. 12.0% of Alliance Pharma shares are held by company insiders. Comparatively, 34.7% of Spire Healthcare Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Alliance Pharma has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500. Comparatively, Spire Healthcare Group has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500.
Spire Healthcare Group has a net margin of 1.96% compared to Alliance Pharma's net margin of -18.34%. Spire Healthcare Group's return on equity of 4.00% beat Alliance Pharma's return on equity.
Summary
Spire Healthcare Group beats Alliance Pharma on 13 of the 19 factors compared between the two stocks.
Get Alliance Pharma News Delivered to You Automatically
Sign up to receive the latest news and ratings for APH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alliance Pharma Competitors List
Related Companies and Tools
This page (LON:APH) was last updated on 11/21/2024 by MarketBeat.com Staff
